Table of Contents
What changed
Net operating income rose 10.5% to $321.3m, but profit before tax fell 45.3% to $57.2m and reported NPAT fell 47.9% to $38.8m. The effective tax rate lifted to 32.1% from 28.7%, so PBT is the cleaner operating read and still prints a 45% decline. Underlying NPAT, as disclosed by the company, was $46.9m — above the "at least $45m" guidance, implying roughly $8.1m of items excluded from the underlying measure that are not reconciled in the extract.
ROE fell to 3.2% from 6.6%. The final dividend was cut to 2.0 cents per share from 3.0 cents (-33%). As a finance company, the bulk of the headline cash and borrowings movements reflect balance-sheet management rather than operating performance: cash fell to $356.2m from $629.6m, and the extracted gross borrowings line dropped to $825.5m from $7.99bn, which reflects a change in what the extracted borrowings line captures (prior year aggregated deposits and other borrowings) rather than a genuine deleveraging event.
Segment mix (FY25 only; no prior comparison supplied): Australian Banking Group contributed ~30.4% of NOI, Motor ~23.5%, Reverse Mortgages ~18.2%. Reverse Mortgages ($52.8m result on $58.3m revenue) and Rural ($27.5m on $34.7m) carry the highest margins; Personal lending was loss-making (-$1.0m on $5.0m).
What matters
- PBT down 45% despite 10.5% revenue growth. The gap between top-line growth and profit collapse points to impairment and/or margin reset in the NZ lending portfolios flagged by management at 1H25, not a revenue problem.
- The H1–H2 shape is extreme. HY25 NPAT was just $3.6m (9.3% of full year) against 48.3% of full-year revenue; H2 delivered $35.2m of NPAT on $166.0m of revenue. Whether that is a genuine run-rate recovery or a provisioning reversal is the key question for FY26.
- Dividend cut alongside weaker ROE. Payout ratio against reported NPAT rose to 48.3% from 30.5% even as the absolute DPS was reduced, signalling management is funding the distribution out of a materially smaller earnings base.
Expectations
The only quantified target provided is the underlying NPAT floor of $45m, which was met ($46.9m). No numeric FY26 target was captured despite the release referencing an FY26 outlook. Against H1 commentary, the release says Heartland "substantially met" 1H25 expectations, consistent with the $35.2m H2 NPAT implied by the interim context. What the release does support: underlying guidance delivery and a sharp H2 improvement. What it does not support without further disclosure: a durable FY26 earnings trajectory, given the absence of a quantified outlook and no bridge on the $8.1m underlying-to-reported gap.
Quality of result
For a lending business, the more telling quality signals are the PBT decline, the effective tax rate step-up, and the underlying adjustment. Reported earnings fell almost twice as fast as PBT's gap with NOI growth would suggest at steady tax, so a portion of the NPAT weakness is tax-driven rather than operational. The H2 recovery is sizeable but not decomposed between net interest margin recovery, lower impairment charges, or provision unwinds, so its durability is not demonstrated in the extract.
Operating cash flow of $673.2m and pre-lease FCF of $668.8m are not meaningful FCF indicators for a finance company — they reflect movements in deposits and the receivables book rather than distributable cash. Capex of $4.4m (vs $28.1m prior) is notably light and flatters the FCF optics. FX also detracted modestly, with a $2.0m negative exchange effect on cash (versus a $1.8m positive in FY24).
Unresolved
- What specifically drove the $8.1m gap between reported NPAT ($38.8m) and underlying NPAT ($46.9m), and are any of those items recurring?
- What was the impairment charge in FY25 versus FY24, and how much of the H2 recovery came from lower provisioning versus core margin?
- Why did the effective tax rate rise to 32.1%, and is that rate expected to persist?
- What is the actual total deposits and borrowings position at 30 June 2025, given the extracted borrowings line appears to capture only "other borrowings"?
- Was the 2.0 cent final dividend accompanied by an interim, and what is the full-year DPS versus the prior year's full-year DPS?
- What is the FY26 underlying NPAT outlook in quantitative terms?
This briefing cannot assess credit quality trends, net interest margin, capital ratios, or the FY26 guidance range because none of those disclosures were captured in the extracted data.
Key metrics
| Metric | FY25 | FY24 | Change |
|---|---|---|---|
| Revenue | $321.3m | $290.7m | +10.5% ↑ |
| Net profit after tax | $38.8m | $74.5m | -47.9% ↓ |
| Net cash inflow from operating activities | $673.2m | $928.4m | -27.5% ↓ |
| Final dividend per share | 2.0c | 3.0c | -33.3% ↓ |
| Operating profit | $128.7m | $151.3m | -14.9% ↓ |
| Profit before tax | $57.2m | $104.5m | -45.3% ↓ |
| Cash and cash equivalents | $356.2m | $629.6m | -43.4% ↓ |
| Total assets | $8647.5m | $9291.9m | -6.9% ↓ |
Reference: annolyse.ai/briefings/hgh-fy25
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Motor | $75.5m | — | $47.6m | n/a |
| Reverse mortgages | $58.3m | — | $52.8m | n/a |
| Personal lending | $5.0m | — | −$1.0m | n/a |
| Business | $53.8m | — | $1.9m | n/a |
| Rural | $34.7m | — | $27.5m | n/a |
| Australian Banking Group | $97.7m | — | $42.5m | n/a |
Reference: annolyse.ai/briefings/hgh-fy25
Analytical metrics
| Metric | FY25 | FY24 | Context |
|---|---|---|---|
| PBT growth | -45.3% | — | cleaner earnings measure |
| Effective tax rate | 32.1% | 28.7% | — |
| FCF pre-lease | $668.8m | $900.3m | −$231.5m |
| FCF / NPAT | n/m | n/m | complementary conversion metric |
| Capex % revenue | 1.4% | 9.7% | — |
| Capex | −$4410.0m | −$28.1m | −$4381.9m |
| Trade debtors | — | $0.2m | — |
| Net debt | $469.2m | $7360.3m | −$6891.0m |
| Gross borrowings | $825.5m | $7989.9m | −$7164.4m |
| Payout ratio vs NPAT | 48.3% | — | — |
| Payout ratio vs FCF pre-lease | 2.8% | — | covered |
| ROE (annualised) | 3.2% | 6.6% | Weakening |
| HY25 share of FY25 revenue | 48.3% | — | Other half was 51.7% |
| HY25 share of FY25 NPAT | 9.3% | — | Other half was 90.7% |
Reference: annolyse.ai/briefings/hgh-fy25
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.